Dr. Frank A. Vicini

  • Radiation oncologist
  • Spoken languages English


Frank A. Vicini, MD, FACR, FASTRO, FABS has held multiple academic appointments and has been involved in numerous clinical studies involving breast and prostate cancer. He has designed, developed and completed numerous phase I/II and III NIH/NCI clinical trials to evaluate new and improved techniques to treat patients with Stage I and II breast cancer. Dr. Vicini has authored over 300 peerreviewed articles and presented his research at national and international meetings. He is a visiting professor in both the United States and Europe, authored multiple chapters in textbooks and is on the editorial board of several oncology journals. In addition, he is listed as one of the few oncologists in “Best Oncology Doctors in America.” Dr. Vicini was recently named GenesisCare Oncology’s National Principal Investigator.

Career Positions

Current position(s)

  • GenesisCare - Radiation Oncologist, Royal Oak, MI

Past position(s)

  • Past position: William Beaumont Hospital - Chief of Oncology, Royal Oak, MI
  • Past position: Oakland University William Beaumont School of Medicine - Professor Radiation Oncology, Royal Oak, MI
  • Past position: Oakland University School of Health Sciences - Clinical Professor of Medical Laboratory Science, Rochester, MI



  • Michigan State University, BS, Biochemistry and Agronomy, East Lansing, MI
  • Wayne State University School of Medicine, Detroit, MI


  • William Beaumont Hospital, Radiation Oncology, Chief Resident, Royal Oak, MI


  • William Beaumont Hospital, Rotating Program, Royal Oak, MI


  • Harvard Medical School Joint Center for Radiation Therapy, Breast Cancer Fellowship, Boston, MA

Expertise And Interests


  • Breast, Prostate


Awards and honors

  • Best Doctors in America, Strathmore's Who's Who, Top 318 Cancer Doctors for Women: Good Housekeeping, America's Top Doctors for Women, Castle & Connolly Guide: Top Doctors In America, "Top Doctor" 2013 Award by HOUR Detroit


  • Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates
  • Targeted Intraoperative Radiotherapy for Early Breast Cancer

Clinical studies

Primary Objective To assess the benefit of docetaxel as measured by improvement in freedom from progression (phase II) and subsequently metastasis free survival (phase III) when given in combination with radiation and androgen deprivation in treatment of high risk prostate cancer post-radical prostatectomy.

View Study

Frank Vicini's Reviews


based on 139 Ratings 33 Comments


Dr. Vicini is a great doctor and I recommend him to anyone.


There is nothing I can think of that would be necessary to improve the quality of care given by these wonderful people.


Nothing. I love Dr. Vicini and his PA. Everyone at this place is super nice and respectful!


Staff and Doctors ROCK!!

Read More

Ratings and Comments Powered by NRC Health